PECAM1 and breast carcinoma: CXCL1/2-CXCR2 axis may involve in breast cancer progression, and Ly6G+CD11b+ cells sorted from tumor tissues express higher levels of CXCR2 than Ly6C+CD11b+ cells, F4/80+ cells and CD31+ cells [27].